Mr. Guoqiang Wang has worked in the Ministry of Health, the China Food and Drug Administration and the National Family Planning Commission (NFPC) for many years. In December 2000, he served as a member of the Party Leadership Group and as Deputy Director of the NFPC. In March 2003, he again served as a member of the Party Leadership Group and became Deputy Director of the National Population and Family Planning Commission (NPFPC), the renamed NFPC. In September 2003, he acted concurrently as the Party Secretary of Departments and the President of the Party School of Departments, both under the NPFPC. He became the Managing Vice Chairman of the China Population Association in June 2002 and was promoted to the position of Vice Chairman in December 2007.

Since 2007, he has served as Secretary of the Party Leadership Group, Deputy Minister of the Ministry of Health, and Director of the State Administration of Traditional Chinese Medicine.

Professor Jiefu Huang is a world-class surgeon who still keep clinical practice and a distinguished administrator who plays active role in China’s medical profession. He is the one who successfully performed the first Chinese liver transplantation in 1994, and first Asian combined liver-kidney transplantation in 1997.He is acknowledged as the academic leader to start the liver transplantation development in China by Chinese transplant professional. He plays a vital role in the promulgation and implementation of the organ transplantation regulation in China. Being the Chairman of National Organ Donation and Transplantation Committee, he has orchestrated the entire organ transplantation reform and developed a deceased organ donation program as an ethical alternative source of organs, ending the use of executed prisoner’s organs. He was the laureate of GUSI Peace Prize 2015 and Wu Jie ping Medicine Award 2015 for his outstanding contribution. As president of China’s Hospital Association and Dean of the hospital management research institute of Tsinghua university, he is involved in China’s public hospital’s reform. He is highly recognized as a prominent leader in China’s healthcare reform by domestic and international medical communities.

Mr. Diego Aulestia Valencia is a development economist holding a Master’s Degree in Economics (1991) at the University of Oregon (USA), and in Latin American Studies, at the London’s School of Economics. He has also pursue graduate studies in history and urban studies.

Before being appointed as Permanent Representative of Ecuador to the WTO, the Ambassador was Director of the School of Government at the Univesidad de los Hemisferios (Ecuador). As an academic he has taught in Ecuador and Venezuela, and presented lectures in the United States, England, Mexico and France. In 2017 he was named Senior Associate at the Great Cities Institute in the University of Illinois at Chicago (USA). He has published several articles on urban issues, international economics and history.

Former Minister of International Trade (2915-2016); Urban Development and Housing (2013-2015) and Executive President of Ecuador’s Development Bank, Ambassador Aulestia also carries an extensive experience in public and development economics. As overseas duties he was appointed Ambassador of Ecuador in Portugal (2012-2013) and Representative for trade affairs to Europe (2013).

Between 2001 and 2005 he was senior executive if CAF, the Development Bank of Latin America (Caracas, Venezuela), being involve of sovereign lending in social developments. Previously he work in Ecuador in Commercial Banking and Corporate Finances.

Dr. Hu earned his Ph.D. from University of Gothenburg and Chalmers University of Technology, and received his postdoctoral training at University of British Columbia. He is a guest professor at the Chinese University of Hong Kong and the Cardiovascular Research Institute of Shanghai. Currently, he is Director of Shenzhen Stem Cell Engineering Technology Research and Development Center, Vice Chairman of Chinese Industry and Innovation Technology Strategic Alliance of Stem Cells and Regenerative Medicine, Vice Chairman of China Institute of Strategy & Management (CISM), Member of Committee of International Advisers for the United Nations International Children's Emergency Fund, Chairman of Shenzhen Beike Biotechnology Co., Ltd, as well as Honorary Chairman of World Health Foundation. He has several international and domestic patents in the clinical application of adult stem cells.

John Speakman obtained his PhD at the University of Stirling, Scotland in 1984 and immediately afterwards went to the University of Aberdeen, Scotland, where he was successively a lecturer, senior lecturer, reader and ultimately made Professor in 1997. Between 2007 and 2011 he was Director of the Institute of Biological and Environmental Sciences. In 2011 he took up a position as a 1000 Talents ‘A’ professor at the Chinese Academy of Sciences Institute of Genetics and Developmental Biology in Beijing. His research primarily concerns the causes and consequences of inter-individual variation in energy expenditure, including impacts of calorie restriction. He has published over 500 peer reviewed scientific papers, including 11 times in Nature and Science and twice on the cover of Nature. He has been awarded several international prizes including the Zoological Society of London scientific medal, and the Royal Society of Edinburgh/Saltire Society Scottish Science Medal. In 2016 he was the first Briton to be awarded the Chinese Academy of Sciences prize for international co-operation. In 2018 he was elected a Fellow of the Royal Society (FRS). He is on the board of reviewing editors at Science.

Howard Taylor has lived in Africa, Asia, Europe and the US. He has led a global corporate foundation, established a creative social enterprise, built government teams, and led a UN-hosted global partnership – all to improve the lives of millions of people.

As Vice-President and Managing Director of the Nike Foundation, Howard was the driving force behind the successful spin-out of Girl Effect as an independent, a creative social enterprise that uses branded mass and social media, technology and data to tackle negative social norms and change behaviours.

Prior to Nike, Howard held senior roles across the UK Government, including at the Department for International (DFID), Cabinet Office and Foreign Office. He was Chief of Staff to two Secretaries of State for International Development and led DFID’s country programmes in India and Ethiopia. In Ethiopia, he co-chaired the Development Assistance Group, responsible for coordinating the most impactful investment of over $3 billion/year of official development assistance.

Howard serves on the Board of Mercy Corps (Europe) and the WePROTECT Global Alliance, and is a member of the International Telecommunication Union Broadband Commission Working Group on Child Safety Online. He is married with two children and enjoys sports, arts, politics, and pursuing inspirational ideas that can change the world.

Mr. Daiming Fan is an Academician of the Chinese Academy of Engineering and a Foreign Fellow of the Academy of Medical Sciences of the United States. He currently serves on the Education, Science, Culture, and Public Health Committee of the 13th National People's Congress, and is Vice President of the China Anti-Cancer Association; Vice President of the Asian Pacific Association of Gastroenterology; President of Xijing Hospital of Digestive Diseases of the Fourth Military Medical University; Director of the State Key Laboratory of Cancer Biology; Director of the National Clinical Research Center for Digestive Disease; an executive member of the Union for International Cancer Control; a member of the State Science and Technology Awards Commission; and a member of the State Textbook Committee. He is also the director of a national drug clinical trial institution.

Previously, Mr. Fan has served as Vice President of the Chinese Academy of Engineering; President of the Fourth Military Medical University; President of the Chinese Society of Gastroenterology; and President of the 2013 World Congress of Gastroenterology. He was selected as a delegate to the 14th CPC National Congress, and as deputy of the 11th and 13th National People's Congress. He was one of the first scholars funded by the National Science Fund for Distinguished Young Scholars, and one of the first Changjiang Distinguished Professors.

Mr. Fan has long been engaged in the clinical research of digestive diseases. With a special interest in studying macromedical strategies, he first proposed the theory of holistic integrative medicine and applied it in his research. He has participated in a large number of research projects, including the National Basic Research Program of China (973 Program), the 863 Program, the National Key Technology R&D Program, the National Major Scientific and Technological Special Project for "Significant New Drugs Development," the Key Program of the National Natural Science Foundation of China, and a major consulting project with the Chinese Academy of Engineering. His accomplishments in these projects have been recognized through several prestigious awards and honors, including the National Science Progress Award for Innovation Teams; the National Science Progress Awards; the State Technological Invention Award; the Military National Science and Technology Progress Award; the Military Teaching Achievements Award; and the Science and Technology Progress Award of Shaanxi Province. He has also received 38 China Invention Patents, 18 Utility Model Patents, and a New Drug Certificate. His honors also include the French National Academy of Medicine Servier Prize, the Ho Leung Ho Lee Foundation Science and Technology Progress Award, the Qiu Shi Practical Project Prize, and the "Science Chinese" Outstanding University President Prize. Mr. Fan has authored 31 books, and is also the Editor-in-Chief of the National Higher Medical Education Digital Textbooks, the Preclinical Medicine Intensive Reading Book Series, and the Cancer Research Frontier. He has been invited to serve as an editorial board member, associate editor, or editor by 13 international journals, including Nature Reviews Gastroenterology & Hepatology, Gut, and Hepatology. He has also published nearly 700 papers in top journals such as The Lancet, Nature Medicine, Nature Reviews Gastroenterology & Hepatology, Nature Clinical Practice Oncology, and Gut. He has supervised 186 graduate students and doctoral students. In 2010, Mr. Fan was awarded a First-Class Merit by the Central Military Commission for his outstanding achievements.

As a passionate and active advocate for sustainability for over two decades, Esther has been instrumental in establishing CDL’s leadership in sustainability and ESG best practices. These include publishing the first sustainability report using GRI standards in Singapore in 2008 and issuing the first green bond by a Singaporean company in 2017. A forerunner in embracing the UN SDGs, Esther was conferred 2018 SDG Pioneer for Green Infrastructure and A Low Carbon Economy by the UN Global Compact.

She sits on the boards or advisory platforms of a number of global organisations including the World Green Building Council, Singapore Green Building Council, UNEP Finance Initiative Real Estate Group, GRI Corporate Leadership Group, Asia Pacific Real Estate Association Singapore Chapter Board and Global Compact Network Singapore. Esther founded the Women4Green Network as she believes in empowering women to drive sustainable practices at home, at work and at play.

Dr Nina Anchugina has previously worked as an economist and data scientist in the banking, mining and social policy sectors and has a PhD in Mathematics from the University of Auckland, New Zealand (2017).

CSDA is a translational research centre based in New Zealand and working worldwide on projects that use data analytics for social good. CSDA leads a range of projects with government agencies, helping them to use rich data to address significant social challenges in sectors including child protection and homelessness. The centre is well known for delivering the Allegheny Family Screening Tool, a child protection predictive risk model built using administrative data, which has been used as a decision support tool in Allegheny County (PA, United States) since 2016.

At CSDA Nina leads translational predictive risk modelling research projects with human services agencies as well as taking a lead role on operations and strategy.

Dr. Awni Behnam began his public schooling in the United Kingdom, 1953-1959. After serving as commanding officer in the Navy, (Iraq) 1962-1969 he joined the University of Wales (UWIST) UK in 1972. and lectured in the Department of Maritime Studies,1974- l977 where he completed his higher education (MSc., PhD).

He joined the United Nations at UNCTAD,Geneva, in 1977 as Economic Affairs Officer and Assistant to the Director in the Shipping Division of UNCTAD before assuming responsibility as the Chief of Liaison to the Group of 77 for the Secretary-General of UNCTAD. He was involved in the elaboration of several UNCTAD conventions in the maritime disciplines. He was promoted in 1992 to the post of the Secretary of the Trade and Development Board of UNCTAD and UNCTAD Conferences which he organized between 1996 and 2004.

In 2000 he was promoted to the rank of Senior Advisor to the Secretary General of UNCTAD. He was a close collaborator and friend of the IOI founder Elisabeth Mann Borgese from 1974. In 2004 he was elected to post of President of the International Ocean Institute, (Malta) and in 2012 reappointed as the Honorary President of IOI a post was held by Elisabeth Mann Borgese.

In 2008 he was invited by the UN Secretary General Ban Ki moont o assume the responsibility of UN Commissioner General for the UN Pavilion at the Shanghai World Expo 2010 as UN Assistant Secretary -General.

In December 2011 he was appointed with four other Experts to draft the initiative of the UN Secretary Generals the Ocean Compact and co-chaired NGO cluster at RIO +20. He also Directs the Malta Regional Training Course of IOI.

Dr. Behnam has received several international and national awards and honorary professor posts and has a large number of publications to his name. He is the author of the Blue Economy concept. Dr. Behnam holds a first degree in Business Administration (BA Mustensiriya University — 1968), a Masters (MSc.) in Development Economics and a Doctorate (PhD) from the University of Wales (1974 and 1976 respectively).

Born in Mousel, Iraq in 1940, he became a Swiss citizen in 1994. On the occasion of the entry of Switzerland to the UN, the Swiss Authorities honoured him with Swiss Diplomatic Passport for the duration of his service in the UN. He is married with two children and five grandchildren.

Mr. Miguel R. Bautista has over two decades of experience in economic and multilateral affairs. As Secretary of the Trade and Development Board, Mr. Bautista is tasked with facilitating the smooth functioning of the intergovernmental machinery in order for UNCTAD to fully contribute to the accomplishment of the global development agenda.

Before joining UNCTAD, Mr. Bautista was a career Philippine diplomat. As such, he served at the Permanent Missions of the Philippines to the United Nations in Geneva and in New York. He also served as Philippine Consul in New York, and as Head of Political Section at the Philippine Embassy in Riyadh.

He was a member of the international relations faculties of Miriam College in Quezon City and the College of St. Benilde in Manila. Mr. Bautista is also a regular contributor to the United Nations Institute for Training and Research in the areas of diplomatic skills training and development, multilateral diplomacy and conference management.

Mr. Bautista has been awarded the Order of Rizal (Philippines), the Order of Bernardo O’Higgins (Chile) and the Order of Rio Branco (Brazil). He has also been decorated for his service in the reserve of the Philippine Coast Guard where he currently holds the rank of Captain and where he earned the Outstanding Achievement, Merit, and Search and Rescue medals.

He earned his Bachelor of Arts in humanities, summa cum laude, from Matteo Ricci College at Seattle University, and his Masters in Public Administration with highest academic honours from the University of Illinois at Chicago, United States of America.

His Excellency Chad Blackman, is the Ambassador and Permanent Representative of Barbados to the United Nations and Other International Organizations in Geneva.

His Excellency Chad Blackman, is the Ambassador and Permanent Representative of Barbados to the United Nations and Other International Organizations in Geneva. Ambassador Blackman has worked in the international development sector for over fifteen years, and has worked as an international trade law specialist and development consultant respectively.

He has served as a youth development consultant with the Commonwealth Secretariat in London and was Senior Partner in an international law firm specializing in tax, trade and data protection laws.

Currently, Ambassador Blackman is the Chair for the Trade and Development Committee in the World Trade Organization (WTO) and Chair of the SIDS Group in the United Nations Conference on Trade and Development (UNCTAD) respectively.

He has undertaken both the LLB Law and LLM International Trade Law at the University of Essex in the United Kingdom. Additionally, His Excellency is an Associate member of the Chartered Institute of Arbitrators.

Sally joined the Global Partnership to End Violence Against Children in March 2018, where she oversees people, finance and operations for the Partnership Secretariat, as well as investments from the Fund to End Violence Against Children.

Prior to this role, she worked for UNICEF for many years, most recently leading diverse advocacy initiatives with governments and business to advance the cause of children, including through multi-stakeholder platforms and initiatives, such as the World Economic Forum and the UN Global Compact. She also led the development of UNICEF’s strategic framework for partnerships in 2012, and managed relationships with some of UNICEF’s major government partners. In 2002-2006, she worked in the office of former UN Secretary-General Kofi Annan on special political assignments and as Executive Officer.

An Australian national, Sally began her career in external relations and communications, including with the UNICEF-led Operation Lifeline Sudan, based in Nairobi, and later in support of the Balkans team during the 1999 Kosovo crisis. She also worked with UNICEF’s Division of Communication in New York; the UN-UNICEF joint office in Sydney (covering Australia, New Zealand and the Pacific); and with three National Committees for UNICEF – Australia, New Zealand, and the United Kingdom. She holds a Master’s degree in human rights from the University of London’s Institute of Commonwealth Studies.

Mr. Dongchen Cai, senior engineer, Chairman of the China Shijiazhuang Pharmaceutical Companies (CSPC).

Mr. Cai also serves as Chairman of the China Antibiotic Industry Technology Innovation Strategic Alliance, a member of the assessment committee of "Major New Drug Creation Project" under the "National Medium- and Long-Term Science and Technology Development Plan" and a member of the National Biological Industry Development Expert Advisory Committee. He is also an honorary professor of the University of International Business and Economics, Hebei University of Science and Technology, Hebei University of Technology. Mr. Cai has achieved quite a number of awards such as the National Model Worker, National "May 1st" Labor Medal, the Top Ten Outstanding Entrepreneurs of Chinese Medicine, the Chinese Environmental And Public Welfare Entrepreneur, Outstanding Persons for 60-year Chinese Medicine, the Beijing First Prize of Science and Technology Award, Special Award of Hebei Provincial Governor, Excellent Entrepreneurs of Hebei Province, Top Ten Outstanding Entrepreneurs with Social Responsibility of Hebei Province, the First Prize of Hebei Science and Technology Progress Award, Excellent Expert of Hebei Province, and Outstanding Entrepreneur Contributor of Shijiazhuang. In addition, Mr. Cai is also keen on public welfare undertakings, and has established the Hebei CSPC Puen Charity Foundation to help young students with economic needs realize their dreams.

Mr. Junhui Chen is Director of the Interventional and Cell Therapy Center of Peking University Shenzhen Hospital (PUSH), Vice Chairman of the PUSH Expert Committee, and head of the Clinical Project of PUSH National Stem Cell Clinical Research Institute. He currently serves as the Vice Chairman of the Committee of Rehabilitation and Palliative Care of the China Anti-Cancer Association (CACA); Vice Chairman of the Expert Committee on Cancer Prevention and Treatment of the CrossStraits Medicine Exchange Association; Vice Chairman of the Cancer Pain Study Committee of the China Association for the Study of Pain; Vice Chairman of the CSCO Photodynamic Therapy Committee; and Vice Chairman of the Lung Cancer Comprehensive Treatment Branch, Minimally Invasive Cancer Therapy Committee of CACA.

As a professor, chief physician, and postdoctoral supervisor, Mr. Chen has led over 20 research projects, including projects funded from the 863 Program; subprojects under the 12th Five-Year Plan and 13th Five-Year Plan; NSFC-funded projects; projects funded by the State Administration of Traditional Chinese Medicine of the PRC; projects funded by the Natural Science Foundation of Guangdong Province; and projects covered by Shenzhen Scientific and Technological Plans. He has authored and coauthored five books and published over 100 papers, including 30 in SCI journals. He was granted two invention patents in China and won two ministry-level prizes in the Science and Technology Progress Awards. Mr. Chen is on the editorial board of several journals, including Chinese Journal of Clinical Oncology, Chinese Journal of Clinical Oncology and Rehabilitation, Journal of Modern Oncology, Chinese Journal of Interventional Imaging and Therapy, China Modern Medical & Clinical, and The Journal of Practical Medicine.

Audrey Chia is Programme Management Chair of the MSc. Environmental Management Programme which is supported by 9 faculties and schools across NUS. Using leadership and change as theoretical foundations, Audrey studies how health, environmental and social problems can be addressed by social entrepreneurship and innovative philanthropy. Her research has been published in JAMA (Journal of the American Medical Association) and the Academy of Management. She has served as an expert on social entrepreneurship, philanthropy, innovative financing and inclusive growth at meetings of the ADB, OECD, United Nations, the Asia-Pacific Leaders’ Malaria Alliance. Her work has been presented at conferences of the Academy of Management, the Integrated Care Foundation, the European Union Workplace Innovation Network, the World Health Summit and the Xiong An International Health Forum.

Audrey directs NUS Business School’s Leadership Development Programme, which attracts senior executives from five continents. From 2011-2017, she was Programme Director of the NIHA (NUS Initiative to Improve Health in Asia) Healthcare Leadership Programme for senior leaders in the public, private and NGO sectors from 15 countries across Asia.

Mario (Mago) Clerici received his MD (honors) in 1985 and a postgraduate degree in Internal Medicine in 1990 from the University of Milano and then became an Associate Professor and a professor there. He directed the PhD School of Molecular and Translational Medicine at the University of Milano from 2010 to 2017, and from 2017 he has been the Head of the Department of Physiopathology and Transplantations at the same University. Since 2008, he has also been the Scientific Director of the Santa Maria Nascente IRCCS, Don Gnocchi Foundation in Milano. From 2010, he has been a scientific advisor at King Saud University in Riyadh (KSA). He has authored more than 600 papers and has been awarded national and international prizes. He has also been involved in a number of international Scientific Boards and serves as an editor on a number of scientific journals.

Professor Clerici is a clinical investigator with a remarkable track record of innovative research in the immunopathology of human diseases. His research dealt with HIV infection, immunopathology of non-transmittable conditions, conscious of their importance to global health etc. And he has got numerous achievements. Aside from his pioneering research, Professor Clerici has trained a number of immunologists and enriched our human knowledge by his lectures, articles, and his contributions to scientific conferences.

Ms. Limei Deng has been studying Cordyceps for 25 years. With so many years’ practical experiences and being taught carefully by old Tibetan doctors in Yushu, she has mastered the characteristics of Cordyceps sinensis. What is more important is that she has summed up the nutrient production technology of Cordyceps sinensis and the storage technology that can have Cordyceps sinensis to maintain nutrients for a long time.

Prof. Charron Dominique got his education to PhD in France, and had his Post-doctoral Fellow and Senior Post-doctoral Fellow in the Department of Immunology, University of Stanford, USA, majoring in Immunology.

Prof. Charron Dominique is a Professor Emeritus of Immunology in Université Paris-Diderot and a Medical Advisor for International Biology. He is also an honourable professor, professor advisory, or visiting professor in universities and research institutions in various countries, including France, Germany, Canada and China etc. He was a founder of HLAetMédecine（1990-）, EISBM – European Institute for System Biology and Medicine (2014-) etc. and had positions in Ecole Doctorale B2T – Université Paris Diderot (Council), Deutsche Krebschilfe (Scientific Council) Germany, EFI (European Foundation of Immunogenetics) (Scientific Council) and so on. He has been an editor or member of the editorial committee of various international magazines, such as Tissue Antigens, Scandinavian Journal of Immunology, Human Immunology, European Journal of Immunogenetics. Due to his achievement, he got a series of awards and distinctions, such as Rose Payne Award American Society of Histocompatibility & Immunogenetics (ASHI) (2017) and over ten France domestic ones.

He has published 500 papers and articles in international publications and medline versions, for instance, Blood, Nature, Cell, Cancer, Int Immunol, Human Immunol, Transplantation.

Ms. Estabillo has been in the child protection work for over two decades, including overseeing a Child Helpline in a reputable media-based welfare organization to becoming the manager of its Manila and Regional based operations. She was an Unsung Hero awardee in the 2016 Lopez Achievement Award and on the same year also became the Deputy Regional Representative and Advocacy Representative of Child Helpline International (CHI) for Asia Pacific Region. She has also been invited as speaker, panelist and delegate to various national and international conferences.

On September 2017, she joined Plan International Philippines as Manager for Cyber-Safe Spaces project, a Child Online Protection project that focuses in combating Online Sexual Exploitation of Children (OSEC). She leads, oversees, build alliances and represent Plan International Philippines in important events related to Child Online Protection.

Chris Fabian (@hichrisfabian) leads UNICEF Ventures, which invests in open source technology for the public good. The team focuses on investments that address issues like climate change, job loss, human population movements, and pandemics.

Chris co-founded UNICEF’s Innovation Unit in 2007, and developed the organization’s innovation strategy, as well as advising Secretary-Generals Ban Ki-moon and António Guterres on frontier technology issues including AI, data science, blockchain, and cryptocurrency. His teams created products like RapidPro, an SMS-based platform for moving information with more than 7m users, MagicBox which uses AI to track Ebola and other diseases, and four corridors for building policy around drones and UAVs.

Chris is a Commissioner on Global Health Futures for the Lancet / FT and holds honorary scholar positions at the Chinese Central Academy for Fine Arts, and New York University, as well as Edmund Hillary and Tribeca Disruption Fellowships. He was a member of Time Magazine’s “100 Most Influential People” list in 2013. He holds a Bachelor’s degree in Philosophy from the American University in Cairo and a Master’s in Communication from the New School in New York.

Professor Dapeng Jin is currently Chairman of the Academic Advisory Committee of the Medical Management Research Center of the School of Economics and Management, Tsinghua University and Medical Director General of the China Ice and Snow Programs of the Beijing Winter Olympics. In addition, he is also a Vice President of the China Health Tourism Insurance Industry Innovation Alliance, former Director General of the Beijing Municipal Health Bureau, a Vice President of the China Medical Association, President of the Beijing Medical Association.

Rob is an independent consultant and researcher with interests in venture philanthropy and social entrepreneurship, particularly in Asia. He is an Associate of the Centre for the Study of Philanthropy & Public Good at the University of St. Andrews, Scotland.

Rob originally trained as a synthetic organic chemist, receiving his doctorate from Oxford University, followed by research posts at universities in the US, Switzerland and Ethiopia Following a career spanning 15 years in aid and development, he directed an Oxford-based venture philanthropy fund.

In 2005 Rob was elected the first Visiting Fellow at the new Skoll Centre for Social Entrepreneurship, Said Business School at Oxford University, while also managing the launch and development of the European Venture Philanthropy Association (EVPA) and the European Venture Philanthropy Fund. In 2010 he co-founded the Singapore-based Asian Venture Philanthropy Network (AVPN), to strengthen a community of venture philanthropy funds serving Asia’s social entrepreneurs.

From 2011 - 17, Rob was appointed a Visiting Senior Fellow at NUS Business School, Singapore, where his research interests included innovation in philanthropy, giving circles, angel impact investment and new models of corporate giving. He is a global advisor to Social Ventures Hong Kong, an advisory board member of the Conference Board, and a Fellow of the Royal Society of Arts, Commerce & Manufacturing.